Search Results 7011-7020 of 34490 for oral
Past trainees have been uniformly successful in research, with all fellows successfully submitting and presenting abstracts for poster or oral presentation.
Winner of young neurologist tournament for the best oral presentationEuropean Federation of Neurological Sciences (EFNS). 2010. Travel AwardInternational ...
... Oral Anti-Coagulants \[NOAC\]) * History or current hepatic disease including but not limited to acute or chronic hepatitis, cirrhosis or hepatic failure or ...
The purpose of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation ...
* Participants with DM treated with oral hypoglycemic medications. * Participants with DM treated with one SQ insulin injection daily. * Participants ...
Previous experience with an oral or injectable GLP-1 agonist;; Use of the following within 2 weeks of screening: an other GLP-1 agonist, an NK-1 antagonist ...
... Oral and throat cancer, Salivary gland cancer, Thyroid cancer, Head and neck cancer, Skin cancer, Thyroid nodule, Salivary gland tumor, Laryngeal cancer ...
oral lobe seizure, Seizure , Absence seizure, Febrile seizure. Show more areas of focus for Anthony L. Fine, M.D.. Sanford M. Fineman ...
- Chronic use of oral steroid medications, ketoconazole (except for topical formulations), St. John's Wort, or other IPs is not permitted - Have an active ...
Participation eligibility · Concomitant medical condition that will require oral or injectable steroids during the study. · Currently on a stable regime of more ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.